Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study
Details
Serval ID
serval:BIB_34BED0C92D50
Type
Autre: use this type when nothing else fits.
Collection
Publications
Institution
Title
Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study
Create date
19/07/2024 8:44
Last modification date
20/07/2024 6:06